Bacteria Engineered to Treat Diseases Associated with Hyperammonemia
Synlogic Operating Company, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 62/256,052, filed Nov 16, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,487,764 | Bacteria Engineered to Treat Diseases Associated with Hyperammonemia In force · High confidence | Synlogic Operating Company, Inc. | In force | High confidence | ||
| US 10,933,102 | Bacteria Engineered to Treat a Disease or Disorder In force · Low confidence | Synlogic Operating Company, Inc. | In force | Low confidence | ||
| US 11,618,894 | Bacteria Engineered to Reduce Hyperphenylalaninemia In force · High confidence | Synlogic Operating Company, Inc. | In force | High confidence | ||
| US 11,845,964 | Bacteria Engineered to Treat Diseases Associated with Hyperammonemia In force · Medium confidence | Synlogic Operating Company, Inc. | In force | Medium confidence | ||
| US 12,409,195 | Bacteria Engineered to Reduce Hyperphenylalaninemia In force · Medium confidence | Synlogic Operating Company, Inc. | In force | Medium confidence | ||
| US 11,896,627 | Bacteria Engineered to Treat Metabolic Diseases In force · High confidence | Synlogic Operating Company, Inc. | In force | High confidence | ||
| US 10,273,489 | Bacteria Engineered to Treat Diseases That Benefit from Reduced Gut Inflammation And/Or Tightened Gut Mucosal Barrier In force · Medium confidence | Synlogic Operating Company, Inc. | In force | Medium confidence | ||
| US 11,685,925 | Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tightened Gut Mucosal Barrier In force · High confidence | Synlogic Operating Company, Inc. | In force | High confidence | ||
| US 11,291,693 | Bacteria Engineered to Treat Metabolic Diseases In force · High confidence | Synlogic Operating Company, Inc. | In force | High confidence | ||
| US 9,943,555 | Bacteria Engineered to Reduce Hyperphenylalaninemia In force · Medium confidence | Synlogic Operating Company, Inc. | In force | Medium confidence | ||
| 26 more patents in this group · Pro | ||||||
10 of 36 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 36, including 4 expired.
15 of these are in force and held by Synlogic Operating Company, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.